Overall 18% stocks and 82% cash and equivalents. Stocks position close to unchanged from last week since some of my longs got called away due to options expiration. This was offset by new position in MYGN.
This past few week's rally had me a big un-nerved in that the market went from -25% to -10% in about 3 weeks time without me on board. Sure, I missed the 20% down, but I also missed the +15% up since the bottom. By Thursday, I was twitching and nearly bought some SSO at 21.50, but fortunately, I held off. By Friday, the market turned back down, and I breathed a sigh of relief that the downtrend had re-asserted itself.
The week's winner was MYGN. I bought one lot in each account at 82 on Tuesday AM and posted to my blog. After getting as high as 82.60 on Tuesday, MYGN closed down a little over 81. On Tuesday, some big news came out regarding published recommendation by the American College of Obstetricians and Gynecologists recommending that doctors routinely evaluate whether a patient is at risk of carrying a genetic mutation of the BRCA1 or BRCA2 gene which is a marker for breast cancer. MYGN is the one and only company selling the detection kit. This and the coming 2 for 1 split was enough to rally the stock big. By Thursday, the stock was over 93 on a split adjusted basis before closing at bit over 44 (or 88 split adjusted for the week).
MYGN aside, I didn't do any other trades this week and that was fine. I've been over-trading lately without the results to justify the added activity. So to go a whole week and make only 1 trade - which was a winner - felt good.
Overall down about -4% for the year versus -%8 for the S&P based on Thursday numbers.